1. GPCR/G Protein
  2. GCGR
  3. Glucagon (1-29), bovine, human

Glucagon (1-29), bovine, human  (Synonyms: Glucagon)

Cat. No.: HY-P0082 Purity: 99.91%
Handling Instructions Technical Support

Glucagon (1-29), bovine, human, porcine is a peptide hormone, produced by pancreatic α-cells. Glucagon stimulates gluconeogenesis. Glucagon (1-29), bovine, human, porcine activates HNF4α and increases HNF4α phosphorylation.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

CAS No. : 16941-32-5

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 11 publication(s) in Google Scholar

Other Forms of Glucagon (1-29), bovine, human:

Top Publications Citing Use of Products

    Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382.  [Abstract]

    Glucose production in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h compared to control cells, n = 4.

    Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382.  [Abstract]

    Neat1 level in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h, n = 4.

    Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382.  [Abstract]

    Representative images showing cellular distribution of Neat1_2 (green) and NONO (red) in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h. The graph plots the fluorescence intensity of each probe or protein (y-axis) vs. distance (x-axis) for the corresponding white line.

    Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Nat Metab. 2025 Feb;7(2):367-382.  [Abstract]

    Quantification of paraspeckle numbers in hepatocytes treated with proline, Glucagon (200 nM), or proline+glucagon for 24 h, n = 40 cells per group.

    Glucagon (1-29), bovine, human purchased from MedChemExpress. Usage Cited in: Cell Res. 2023 Apr;33(4):273-287.

    Effect of 10 min treatment with famsin (30 nM) or Glucagon (100 nM) on cellular cAMP levels in mouse primary hepatocytes.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Glucagon (1-29), bovine, human, porcine is a peptide hormone, produced by pancreatic α-cells. Glucagon stimulates gluconeogenesis[1]. Glucagon (1-29), bovine, human, porcine activates HNF4α and increases HNF4α phosphorylation[2][3].

    In Vitro

    Upon binding to its receptor Gcgr, Glucagon activates cAMP-PKA signaling to stimulate hepatic glucose production (HGP) and cause hyperglycemia[1].
    Glucagon stimulates both hepatic kisspeptin1 production and gluconeogenesis[1].
    Glucagon (100 nM) represses CYP7A1 mRNA expression in human primary hepatocytes[3].
    Glucagon (100 nM) increases phosphorylayion of HNF4α[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Western Blot Analysis[3]

    Cell Line: Human primary hepatocytes (H1211, HH1215)
    Concentration: 100 nM
    Incubation Time:
    Result: Resulted in a marked increase in the amount of phosphorylated HNF4α.
    In Vivo

    Low-dose (20 μg/kg) Glucagon increases glycemia and does not stimulate insulin secretion in ambient-fed mice. High-dose (1 mg/kg) Glucagon lowers glycemia compared with PBS control and stimulates insulin secretion in ambient-fed mice[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: C57BL/6J mice (12- to 24-week-old)[4]
    Dosage: 20 μg/kg and 1 mg/kg
    Administration: Administered by i.p. injection; 45 minutes
    Result: Low-dose (20 μg/kg) increased glycemia and did not stimulate insulin secretion.
    High-dose (1 mg/kg) lowered glycemia and stimulated insulin secretion.
    Molecular Weight

    3482.75

    Formula

    C153H225N43O49S

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    Sequence

    His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr

    Sequence Shortening

    HSQGTFTSDYSKYLDSRRAQDFVQWLMNT

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    Sealed storage, away from moisture and light

    Powder -80°C 2 years
    -20°C 1 year

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

    Solvent & Solubility
    In Vitro: 

    H2O : 6.67 mg/mL (1.92 mM; ultrasonic and adjust pH to 3 with HCl)

    DMSO : 2 mg/mL (0.57 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 0.2871 mL 1.4356 mL 2.8713 mL
    5 mM --- --- ---
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 0.2 mg/mL (0.06 mM); Clear solution

      This protocol yields a clear solution of ≥ 0.2 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (2.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 0.2 mg/mL (0.06 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 0.2 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (2.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.91%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O 1 mM 0.2871 mL 1.4356 mL 2.8713 mL 7.1782 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Glucagon (1-29), bovine, human
    Cat. No.:
    HY-P0082
    Quantity:
    MCE Japan Authorized Agent: